{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T08:00:55Z","timestamp":1782115255545,"version":"3.54.5"},"reference-count":7,"publisher":"Japanese Society of Toxicology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2131\/jts.39.507","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T23:05:07Z","timestamp":1400713507000},"page":"507-514","source":"Crossref","is-referenced-by-count":11,"title":["Effect of mirabegron on plasma gonadotropic and steroidal hormone levels in rats after two weeks of oral administration"],"prefix":"10.2131","volume":"39","author":[{"given":"Koichiro","family":"Yuno","sequence":"first","affiliation":[{"name":"Drug Safety Research Laboratories, Astellas Pharma Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Onishi","sequence":"additional","affiliation":[{"name":"Drug Safety Research Laboratories, Astellas Pharma Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Arima","sequence":"additional","affiliation":[{"name":"Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuko","family":"Zaizen","sequence":"additional","affiliation":[{"name":"Kumamoto Laboratory, LSI Medience Corporation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Aoki","sequence":"additional","affiliation":[{"name":"Drug Safety Research Laboratories, Astellas Pharma Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Drug Safety Research Laboratories, Astellas Pharma Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlowe J.","family":"Schneidkraut","sequence":"additional","affiliation":[{"name":"Astellas Research Institute of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Miyamae","sequence":"additional","affiliation":[{"name":"Drug Safety Research Laboratories, Astellas Pharma Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","unstructured":"Astellas Pharma Inc. (2013): Betanis Tablets Japanese prescribing information. http:\/\/www.info.pmda.go.jp\/go\/pack\/2590014F1021_1_05\/ Accessed 12 February 2014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Athanasopoulos, A. and Giannitsas, K. (2011): An overview of the clinical use of antimuscarinics in the treatment of overactive bladder. Adv. Urol.,&nbsp;<b>2011<\/b>, 820816.","DOI":"10.1155\/2011\/820816"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Cooper, K.J., Haynes, N.B. and Lamming, G.E. (1970): Effects of unrestricted feeding during oestrus on reproduction in the underfed female rat. J. Reprod. Fertil.,&nbsp;<b>22<\/b>, 293-301.","DOI":"10.1530\/jrf.0.0220293"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Daniels, W.M.U., Jaffer, A., Russell, V.A. and Taljaard, J.J.F. (1993): &alpha;<sub>2<\/sub>&nbsp;and &beta;-adrenergic stimulation of corticosterone secretion in rats. Neurochem. Res.,&nbsp;<b>18<\/b>, 159-164.","DOI":"10.1007\/BF01474679"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Khullar, V., Amarenco, G., Angulo, J.C., Cambronero, J., H&oslash;ye, K., Milsom, I., Radziszewski, P., Rechberger, T., Boerrigter, P., Drogendijk, T., Wooning, M. and Chapple, C. (2013): Efficacy and tolerability of mirabegron, a &beta;<sub>3<\/sub>-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European&#8211;Australian phase 3 trial. Eur. Urol.,&nbsp;<b>63<\/b>, 283-295.","DOI":"10.1016\/j.eururo.2012.10.016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Takasu, T., Ukai, M., Sato, S., Matsui, T., Nagase, I., Maruyama, T., Sasamata, M., Miyata, K., Uchida, H. and Yamaguchi, O. (2007): Effect of (R)-2-(2-aminothiazol-4-yl)-4&rsquo;-{2-[(2-hydroxy-2-phenylethyl) amino] ethyl} acetanilide (YM178), a novel selective &beta;<sub>3<\/sub>-adrenoceptor agonist, on bladder function. J. Pharmacol. Exp. Ther.,&nbsp;<b>321<\/b>, 642-647.","DOI":"10.1124\/jpet.106.115840"},{"key":"7","unstructured":"Ursino, M.G., Vasina, V., Raschi, E., Crema, F. and Ponti, F. (2009): The &beta;<sub>3<\/sub>-adrenoceptor as a therapeutic target: Current perspectives. Pharmacol. Res.,&nbsp;<b>59<\/b>, 221-234."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/3\/39_507\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:39:50Z","timestamp":1620963590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/39\/3\/39_507\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.39.507","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}